Pages that link to "Q35805182"
Jump to navigation
Jump to search
The following pages link to Atrial fibrillation and ventricular dysfunction: a vicious electromechanical cycle (Q35805182):
Displaying 50 items.
- Atrial fibrillation: effects beyond the atrium? (Q26864877) (← links)
- Arrhythmia-Induced Cardiomyopathies: Mechanisms, Recognition, and Management (Q28268244) (← links)
- The burden of atrial fibrillation: should we abandon antiarrhythmic drug therapy? (Q30350063) (← links)
- Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of Trieste (Q33648699) (← links)
- Prevalence and prognostic significance of left ventricular dysfunction in patients presenting acutely with atrial fibrillation. (Q33908786) (← links)
- Atrial Fibrillation and Delayed Gastric Emptying (Q34058277) (← links)
- Infliximab, an anti-TNF-alpha agent, improves left atrial abnormalities in patients with rheumatoid arthritis: preliminary results (Q34219694) (← links)
- Treatment of atrial fibrillation with a dual defibrillator in heart failure patients (TRADE HF): protocol for a randomized clinical trial (Q34626361) (← links)
- Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factors (Q34782595) (← links)
- Mortality associated with atrial fibrillation in patients with myocardial infarction: a systematic review and meta-analysis (Q34863616) (← links)
- Heart failure and atrial fibrillation: from basic science to clinical practice (Q35138993) (← links)
- Comparison of costs and discharge outcomes for patients hospitalized for ischemic or hemorrhagic stroke with or without atrial fibrillation in the United States (Q35232308) (← links)
- Low Left Atrial Compliance Contributes to the Clinical Recurrence of Atrial Fibrillation after Catheter Ablation in Patients with Structurally and Functionally Normal Heart (Q35857017) (← links)
- How does Chronic Atrial Fibrillation Influence Mortality in the Modern Treatment Era? (Q36021753) (← links)
- Echo-Doppler-derived indexes of ventricular stiffness and ventriculo-arterial interaction as predictors of new-onset atrial fibrillation in patients with heart failure. (Q36550350) (← links)
- Worldwide risk factors for heart failure: a systematic review and pooled analysis (Q36675427) (← links)
- P-wave dispersion: What we know till now? (Q36748471) (← links)
- Atrial Fibrillation as a Prognostic Indicator in Medium to Large-Sized Dogs with Myxomatous Mitral Valvular Degeneration and Congestive Heart Failure (Q37020470) (← links)
- Atrial fibrillation and congestive heart failure (Q37155980) (← links)
- Angiotensin II receptor blockers in the prevention of complications from atrial fibrillation (Q37354665) (← links)
- Atrial fibrillation in acute myocardial infarction: a systematic review of the incidence, clinical features and prognostic implications (Q37358467) (← links)
- Effect of Late Gadolinium Enhancement on the Recovery of Left Ventricular Systolic Function After Pulmonary Vein Isolation (Q37364422) (← links)
- Characterization of a novel multifunctional resveratrol derivative for the treatment of atrial fibrillation. (Q37418226) (← links)
- Diastolic Function in Normal Sinus Rhythm vs. Chronic Atrial Fibrillation: Comparison by Fractionation of E-wave Deceleration Time into Stiffness and Relaxation Components (Q37469050) (← links)
- Mid-term Risk Stratification of Patients with a Myocardial Infarction and Atrial Fibrillation: Beyond GRACE and CHADS (Q37496035) (← links)
- Impact of Atrial Fibrillation On Cardiovascular Mortality in the Setting of Myocardial Infarction (Q37496133) (← links)
- Mortality Risk Associated with AF in Myocardial Infarction Patients (Q37496236) (← links)
- Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial (Q37497560) (← links)
- Statins as antiarrhythmics: a systematic review part I: effects on risk of atrial fibrillation. (Q37632310) (← links)
- Cancer Antigen 125 is Associated with Length of Stay in Patients with Acute Heart Failure (Q37653091) (← links)
- Imaging and atrial fibrillation: the role of multimodality imaging in patient evaluation and management of atrial fibrillation (Q37685806) (← links)
- Sinus rhythm restoration and treatment success: insight from recent clinical trials. (Q37831854) (← links)
- Gene therapy to restore electrophysiological function in heart failure (Q38416938) (← links)
- Comorbidity of atrial fibrillation and heart failure (Q38666884) (← links)
- Antiarrhythmic Drug Therapy for Rhythm Control in Atrial Fibrillation (Q38853630) (← links)
- No decline in the risk of heart failure after incident atrial fibrillation: A community study assessing trends overall and by ejection fraction (Q39001301) (← links)
- Management and 1-year outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events (Q39198562) (← links)
- Left ventricular ejection fraction as therapeutic target: is it the ideal marker? (Q39364624) (← links)
- Is rhythm-control superior to rate-control in patients with atrial fibrillation and diastolic heart failure? (Q42964343) (← links)
- Cancer antigen 125 levels and increased risk of new-onset atrial fibrillation. (Q43485791) (← links)
- Muscarinic stimulation and pinacidil produce similar facilitation of tachyarrhythmia induction in rat isolated atria (Q43650186) (← links)
- Prognostic impact of atrial fibrillation in acute coronary syndromes: results from the ARIAM registry. (Q44512893) (← links)
- Dabigatran etexilate for thromboembolic prophylaxis in non-valvular atrial fibrillation: the RE-LY study and substudies with commentary (Q44699178) (← links)
- Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor (Q46665977) (← links)
- Can valsartan reduce the occurrence of atrial fibrillation in heart failure patients? (Q46722766) (← links)
- Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction (Q48855301) (← links)
- P-wave morphologic characteristics predict cardiovascular events in a community-dwelling population. (Q50926683) (← links)
- Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials (Q51116249) (← links)
- Impact of atrial fibrillation on the cardiovascular system through a lumped-parameter approach. (Q53455084) (← links)
- Recovery of systolic and diastolic function after ablation of incessant supraventricular tachycardia (Q58862393) (← links)